Going Beyond the Spreadsheet to a 4D View of Clinical Trial Feasibility
By the time an enrollment curve starts to disappoint, the decision that shaped it has already been made. The study was not slow to execute—it was built around an incomplete picture of where it could realistically succeed. Most feasibility work draws that picture at the country level, identifying potential high-target geographies to pursue. But the factors that determine whether a trial works sit one layer deeper, at the intersection of four dimensions: data, sites, patients, and what we call Precision in Practice. If any of these dimensions is overlooked, the study architecture is flawed before the first patient is ever screened. To get the full picture, sponsors need to upgrade to a 4D view of clinical trial feasibility.
At Precision for Medicine, we approach the dimensions of feasibility as moving parts of a single living ecosystem. Thus, building a full feasibility picture is akin to assembling a puzzle, where each piece only truly makes sense when it is connected to—and put in
context with—everything else.
THE PROACTIVE FEASIBILITY ADVANTAGE: DESIGNING CLINICAL TRIALS WITH PRECISION FROM DAY ZERO
First patient in, last patient out, database lock, and regulatory submission. Clinical research success is often measured in milestones, but the real determinant of success happens long before any of these markers. For sponsors, the answer lies in a single, often overlooked principle: proactive feasibility.